Drug Patent Number | Company | Drug Patent Title | Drug Patent Expiry | Activity Alert |
---|---|---|---|---|
These drug patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc). | ||||
US5952340 | ROCHE | Use of granisetron for the treatment of postoperative nausea and vomiting |
Sep, 2016
(7 years ago) |
Drug Exclusivity | Drug Exclusivity Expiration |
---|---|
M(M-102) | Apr 29, 2014 |
Market Authorisation Date: 17 September, 2004
Treatment: Post operative nausea and vomiting
Dosage: INJECTABLE;INJECTION